BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 31787104)

  • 1. Interplays between Enterovirus A71 and the innate immune system.
    Chen KR; Ling P
    J Biomed Sci; 2019 Dec; 26(1):95. PubMed ID: 31787104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Progress in Research on Structure, Function and Antiviral of Enterovirus A71 3C Protein].
    Li J; Wen H; Wang Z
    Bing Du Xue Bao; 2015 Jul; 31(4):468-73. PubMed ID: 26524922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune responses against enterovirus A71 infection: Implications for vaccine success.
    Aw-Yong KL; NikNadia NMN; Tan CW; Sam IC; Chan YF
    Rev Med Virol; 2019 Sep; 29(5):e2073. PubMed ID: 31369184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-Like Receptor 3 Is Involved in Detection of Enterovirus A71 Infection and Targeted by Viral 2A Protease.
    Chen KR; Yu CK; Kung SH; Chen SH; Chang CF; Ho TC; Lee YP; Chang HC; Huang LY; Lo SY; Chang JC; Ling P
    Viruses; 2018 Dec; 10(12):. PubMed ID: 30563052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hsp27 Responds to and Facilitates Enterovirus A71 Replication by Enhancing Viral Internal Ribosome Entry Site-Mediated Translation.
    Dan X; Wan Q; Yi L; Lu J; Jiao Y; Li H; Song D; Chen Y; Xu H; He ML
    J Virol; 2019 May; 93(9):. PubMed ID: 30814282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. dsRNA Binding Domain of PKR Is Proteolytically Released by Enterovirus A71 to Facilitate Viral Replication.
    Chang YH; Lau KS; Kuo RL; Horng JT
    Front Cell Infect Microbiol; 2017; 7():284. PubMed ID: 28702377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enterovirus A71 Infection Activates Human Immune Responses and Induces Pathological Changes in Humanized Mice.
    Ke Y; Liu WN; Her Z; Liu M; Tan SY; Tan YW; Chan XY; Fan Y; Huang EK; Chen H; En Chang KT; Chan JKY; Hann Chu JJ; Chen Q
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Advances in Enterovirus A71 Infection and Antiviral Agents.
    Wei Y; Liu H; Hu D; He Q; Yao C; Li H; Hu K; Wang J
    Lab Invest; 2024 Feb; 104(2):100298. PubMed ID: 38008182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinically isolated enterovirus A71 subgenogroup C4 strain with lethal pathogenicity in 14-day-old mice and the application as an EV-A71 mouse infection model.
    Xu Y; Ma S; Zhu L; Huang Z; Chen L; Xu Y; Yin H; Peng T; Wang Y
    Antiviral Res; 2017 Jan; 137():67-75. PubMed ID: 27864074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate Immunity Evasion by Enteroviruses: Insights into Virus-Host Interaction.
    Lei X; Xiao X; Wang J
    Viruses; 2016 Jan; 8(1):. PubMed ID: 26784219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research progress on pathogenic and therapeutic mechanisms of Enterovirus A71.
    Lai J; Li Z; Pan L; Huang Y; Zhou Z; Ma C; Guo J; Xu L
    Arch Virol; 2023 Sep; 168(10):260. PubMed ID: 37773227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic and phosphoproteomic analysis of responses to enterovirus A71 infection reveals novel targets for antiviral and viral replication.
    Lin D; Dong X; Xiao X; Xiang Z; Lei X; Wang J
    Antiviral Res; 2023 Dec; 220():105761. PubMed ID: 37992763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TAR DNA-Binding Protein 43 is Cleaved by the Protease 3C of Enterovirus A71.
    Wo X; Yuan Y; Xu Y; Chen Y; Wang Y; Zhao S; Lin L; Zhong X; Wang Y; Zhong Z; Zhao W
    Virol Sin; 2021 Feb; 36(1):95-103. PubMed ID: 32696397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Essential Role of Enterovirus 2A Protease in Counteracting Stress Granule Formation and the Induction of Type I Interferon.
    Visser LJ; Langereis MA; Rabouw HH; Wahedi M; Muntjewerff EM; de Groot RJ; van Kuppeveld FJM
    J Virol; 2019 May; 93(10):. PubMed ID: 30867299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 3C protease of enterovirus A71 counteracts the activity of host zinc-finger antiviral protein (ZAP).
    Xie L; Lu B; Zheng Z; Miao Y; Liu Y; Zhang Y; Zheng C; Ke X; Hu Q; Wang H
    J Gen Virol; 2018 Jan; 99(1):73-85. PubMed ID: 29182509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global quantitative proteomic analysis profiles of host protein expression in response to enterovirus A71 infection in bronchial epithelial cells based on tandem mass tag (TMT) peptide labeling coupled with LC-MS/MS uncovers the key role of proteasome in virus replication.
    Yajie H; Shenglan W; Wei Z; Rufang L; Tingting Y; Yunhui Z; Jie S
    Virus Res; 2023 Jun; 330():199118. PubMed ID: 37072100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug repurposing of pyrimidine analogs as potent antiviral compounds against human enterovirus A71 infection with potential clinical applications.
    Sun J; Yogarajah T; Lee RCH; Kaur P; Inoue M; Tan YW; Chu JJH
    Sci Rep; 2020 May; 10(1):8159. PubMed ID: 32424333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is a multivalent hand, foot, and mouth disease vaccine feasible?
    Klein M; Chong P
    Hum Vaccin Immunother; 2015; 11(11):2688-704. PubMed ID: 26009802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Attenuated Enterovirus A71 Mutant with VP1-V238A,K244R Exhibits Reduced Efficiency of Cell Entry/Exit and Augmented Binding Affinity to Sulfated Glycans.
    Meng T; Wong SM; Chua KB
    J Virol; 2021 Oct; 95(22):e0105521. PubMed ID: 34468173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra-host emergence of an enterovirus A71 variant with enhanced PSGL1 usage and neurovirulence.
    Sun L; Tijsma A; Mirabelli C; Baggen J; Wahedi M; Franco D; De Palma A; Leyssen P; Verbeken E; van Kuppeveld FJM; Neyts J; Thibaut HJ
    Emerg Microbes Infect; 2019; 8(1):1076-1085. PubMed ID: 31339457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.